Use of particular fatty substances which make it possible to modify the physicochemical properties of the skin and/or the mucous membranes as agents preventing or reducing the adhesion of microorganisms to the latter
OwnerGeraldine Lerebour, Laurence Arnaud-Sebillotteinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use, as active ingredient, in a cosmetic composition or for the preparation of a pharmaceutical composition, of an effective quantity of at least one fatty substance free of carbohydrate units, having a melting point of less than 35° C. and having an interfacial tension of between 6 and 27 mN/m, modifying the physicochemical properties of the surface of the skin and/or of the mucous membranes so as to prevent or reduce the adhesion of microorganisms to the latter.
Claims12
Use, as active ingredient, in a cosmetic composition or for the preparation of a pharmaceutical composition, of an effective quantity of at least one fatty substance free of carbohydrate units, having a melting point of less than 35° C. and having an interfacial tension of between 6 and 27 mN/m, modifying the physicochemical properties of the surface of the skin and/or of the mucous membranes so as to prevent or reduce the adhesion of microorganisms to the latter.
Cosmetic use by topical application of at least one fatty substance free of carbohydrate units, having a melting point of less than 35° C. and having an interfacial tension of between 6 and 27 mN/m as active ingredient in a cosmetic composition intended to reduce bad body odours and/or intended for body hygiene health care.
Cosmetic use by topical application of at least one fatty substance free of carbohydrate units, having a melting point of less than 35° C. and having an interfacial tension of between 6 and 27 mN/m as active ingredient in a cosmetic composition intended to combat comedones and/or dandruff.
Use of at least one fatty substance free of carbohydrate units, having a melting point of less than 35° C. and having an interfacial tension of between 6 and 27 mN/m as active ingredient for the preparation of a pharmaceutical composition intended to be used by topical application to combat mycosis and/or acne.
Dependencies are inferred from the claim text.